Table 3.
Unadjusted analysis of factors associated with cough frequency in patients with interstitial lung disease
| Variable | IIPs (n = 70) | CTD-ILD (n = 49) | CHP (n = 10) | Combined | ||||
|---|---|---|---|---|---|---|---|---|
| ρ | p-value | ρ | p-value | ρ | p-value | ρ | p-value | |
| Age, years | 0.017 | 0.890 | 0.222 | 0.125 | −0.031 | 0.933 | 0.100 | 0.260 |
| Male sex | – | 0.174 | – | 0.441 | – | 0.667 | – | 0.415 |
| Current smoker | – | 0.079 | – | 0.857 | – | – | – | 0.037 |
| Pack-years of smoking | −0.013 | 0.916 | −0.192 | 0.186 | −0.107 | 0.769 | −0.011 | 0.898 |
| Body mass indexa | −0.251 | 0.036 | −0.174 | 0.232 | 0.326 | 0.391 | −0.166 | 0.061 |
| FSSG score | 0.019 | 0.878 | 0.350 | 0.014 | 0.342 | 0.334 | 0.174 | 0.049 |
| MRC chronic dyspnoea scaleb | 0.071 | 0.561 | 0.291 | 0.042 | 0.356 | 0.312 | 0.173 | 0.051 |
| Pulmonary function tests, % predictedc | ||||||||
| FEV1 | −0.083 | 0.508 | −0.040 | 0.786 | 0.038 | 0.923 | −0.098 | 0.279 |
| FVC | −0.160 | 0.201 | −0.114 | 0.439 | 0.017 | 0.966 | −0.120 | 0.187 |
| TLC | −0.236 | 0.056 | 0.028 | 0.849 | −0.126 | 0.748 | −0.172 | 0.057 |
| DLCO | −0.307 | 0.012 | −0.287 | 0.048 | −0.510 | 0.160 | −0.328 | < 0.001 |
| Composite Physiologic Indexc | 0.334 | 0.006 | 0.322 | 0.026 | 0.259 | 0.500 | 0.319 | < 0.001 |
| Medication | ||||||||
| Glucocorticoid | – | 0.642 | – | 0.096 | – | 0.257 | – | 0.012 |
| Antifibrotic agent | – | 0.362 | – | – | – | 0.066 | – | 0.049 |
| Proton pump inhibitor | – | 0.847 | – | 0.241 | – | 0.915 | – | 0.582 |
The Spearman rank correlation was used to assess correlations between the data. The p-values for binary variables were determined using the Mann-Whitney U test. CHP, chronic hypersensitivity pneumonia; CTD-ILD, connective tissue disease-associated interstitial lung disease; DLco, diffusing capacity of the lung for carbon monoxide; FEV1, forced expiratory volume in 1 s; FSSG, frequency scale for the symptoms of gastro-oesophageal reflux disease; FVC, forced vital capacity; IIPs, idiopathic interstitial pneumonias; MRC, Medical Research Council; TLC, total lung capacity. aIIPs (n = 70), CTD-ILD (n = 49), CHP (n = 9); bIIPs (n = 69), CTD-ILD (n = 49), CHP (n = 10); cIIPs (n = 66), CTD-ILD (n = 48), CHP (n = 9)